Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 5699-5708

  Jerse, Ann E ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; GENITAL TRACT INFECTION; GONORRHEA; MOUSE; NEISSERIA GONORRHOEAE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; URETHRITIS; VAGINA SMEAR;

EID: 0032707631     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.5699-5708.1999     Document Type: Article

References (62)

1. Abdullah, M., and A. L. Kierszenbaum. 1989. Identification of rat testis galactosyl receptor using antibodies to liver asialoglycoprotein receptor: purification and localization on surfaces of spermatogenic cells and sperm. J. Cell Biol. 108:367-375.
2. Achtman, M., M. Neibert, B. A. Crowe, W. Strittmatter, B. Kusecek, E. Weyse, M. J. Walsh, B. Slawig, G. Morelli, A. Moll, and M. Blake. 1988 Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J. Exp. Med. 168:507-525.
3. Arko, R. J. 1989. Animal models for pathogenic Neisseria species. Clin. Microbiol. Rev. 2:S56-S59.
4. Barritt, D. S., R. S. Schwalbe, D. G. Klapper, and J. G. Cannon. 1987. Antigenic and structural differences among six proteins II expressed by a single strain of Neisseria gonorrhoeae. Infect. Immun. 55:2026-2031.
5. Black, W. J., R. S. Schwalbe, I. Nachamkin, and J. G. Cannon. 1984. Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect. Immun. 45:453-457.
6. + Neisseria gonorhoeae by limited availability of normal human serum. Infect. Immun. 65:545-650.
7. Braude, A. I., L. B. Corbeil, S. Levine, J. Ito, and J. A. McCutchan. 1978. Possible influence of cyclic menstrual changes on resistance to the gonococcus, p. 328-337. In G. F. Brooks, E. C. Gotschlich, K. K. Holmes, W. D. Sawyer, and F. E. Young (ed.), Immunobiology of Neisseria gonorrhoeae. American Society for Microbiology, Washington, D.C.
8. Centers for Disease Control. 1996. Ten leading nationally notifiable infectious diseases-United States, 1995. Morbid. Mortal. Weekly Rep. 45:8834-8835.
9. + Neisseria gonorrhoeae from the bactericidal action of normal human serum. Infect. Immun. 63:1790-1795.
10. Chen, T., and E. C. Gotschlich. 1996. CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins. Proc. Natl. Acad. Sci. USA 93: 14851-14856.
11. Cohen, M. S., J. G. Cannon, A. E. Jerse, L. M. Charniga, S. F. Isbey, and L. G. Whicker. 1994. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J. Infect. Dis. 169:532-537.
12. Cohen, M. S., and J. G. Cannon. 1999. Human experimentation with Neisseria gonorrhoeae: progress and goals. J. Infect. Dis. 179:5375-379.
13. Connell, T. D., D. Shafer, and J. G. Cannon. 1990. Characterization of the repertoire of hypervariable regions in the protein II (opa) gene family of Neisseria gonorrhoeae. Mol. Microbiol. 4:439-449.
14. Corbell, L. B., A. Chatterjee, L. Foresman, and J. A. Westfall. 1985. Ultrastructure of cyclic changes in the murine uterus, cervix and vagina. Tissue Cell 17:53-68.
15. Cornelissen, C. N., G. D. Biswas, and P. F. Sparling. 1993. Expression of gonococcal transferrin-binding protein 1 causes Escherichia coli to bind human transferrin. J. Bacteriol. 175:2448-2450.
16. Cornelissen, C. N., M. Kelley, M. M. Hobbs, J. E. Anderson, J. G. Cannon, M. S. Cohen, and P. F. Sparling. 1998. The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol. Microbiol. 27:611-616.
17. Dehio, C., S. D. Gray-Owen, and T. F. Meyer. 1998. The role of neisserial opa proteins in interactions with host cells. Trends Microbiol. 6:489-495.
18. Dillard, J. P., and H. S. Seifert. 1997. A peptidoglycan hydrolase similar to bacteriophage endolysins acts as an autolysin in Neisseria gonorrhoeae. Mol. Microbiol. 25:893-901.
19. Eades-Perner, A. M., H. van der Putten, A. Hirth, J. Thompson, M. Neumaier, S. van Kleist, and W. Zimmermann. 1994. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res. 54:4169-4176.
20. Falk, V., and G. Krook. 1967. Do results of culture for gonococci vary with sampling phase of menstrual cycle? Acta Derm. Venereol. 47:190-193.
21. Flemming, T. J., D. E. Wallsmith, and R. S. Rosenthal. 1986. Arthropathic properties of gonococcal peptidoglycan fragments: implications for the pathogenesis of disseminated gonococcal disease. Infect. Immun. 52:600-608.
22. Goldenberg, D. L., P. L. Chisholm, and P. A. Rice. 1983. Experimental models of bacterial arthritis: a microbiologic and histopathologic characterization of the arthritis after the intraarticular injections of Neisseria gonorrhoeae, Staphylococcus aureus, group A streptococci, and Escherichia coli. J. Rheumatol. 10:5-11.
23. Hedges, R. R., M. S. Mayo, L. Kallman, J. Mestecky, E. W. Hook, and M. W. Russell. 1998. Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect. Immun. 66:5826-5832.
24. Hook, E. W., and H. H. Handsfield. 1999. Gonococcal infections in the adult, p. 451-466. In K. K. Holmes, P. F. Sparling, P. A. Mardh, S. M. Lemon, W. E. Stamm, P. Piot, and J. N. Wasserheit (ed.), Sexually transmitted diseases. McGraw-Hill Companies, Inc., New York, N.Y.
25. James, J. F., and J. Swanson. 1978. Studies on gonococcus infection. XIII. Occurrence of color/opacity colonial variants in clinical cultures. Infect. Immun. 19:332-340.
26. James, J. F., and J. Swanson. 1978. Color/opacity colonial variants of Neisseria gonorrhoeae and their relationship to the menstrual cycle, p. 338-343. In G. F. Brooks, E. C. Gotschlich, K. K. Holmes, W. D. Sawyer, and F. E. Young (ed.), Immunobiology of Neisseria gonorrhoeae. American Society for Microbiology, Washington, D.C.
27. Jerse, A. E., M. S. Cohen, P. M. Drown, L. G. Whicker, S. F. Isbey, H. S. Seifert, and J. G. Cannon. 1994. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179:911-920.
28. Johnson, A. P., M. Tuffrey, and D. Taylor-Robinson. 1989. Resistance of mice to genital infection with Neisseria gonorrhoeae. J. Med. Microbiol. 30:33-36.
29. Johnson, D. W., K. K. Holmes, and P. S. Kvale. 1969. An evaluation of gonorrhea case findings in the chronically infected female. Am. J. Epidemiol. 90:438-448.
30. Kallstrom, H., M. K. Liszewski, J. P. Atkinson, and A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647.
31. Kilian, M., J. Mestecky, and M. W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296-303.
32. Kita, E., H. Matsuura, and S. Kashiba. 1981. A mouse model for the study of gonococcal genital infection. J. Infect. Dis. 143:67-70.
33. Kita, E., S. Takahashi, K. Yasui, and S. Kashiba. 1985. Effect of estrogen (17β-estradiol) on the susceptibility of mice to disseminated gonococcal infection. Infect. Immun. 49:238-243.
34. Kita, E., N. Katsui, N., M. Emoto, M. Sawaki, D. Oku, F. Nishikawa, A. Hamuro, and S. Kashiba. 1991. Virulence of transparent and opaque colony types of Neisseria gonorrhoeae for the genital tract of mice. J. Med. Microbiol. 34:355-362.
35. Koch, M. L. 1947. A study of cervical cultures taken in cases of acute gonorrhea with special reference to the phases of the menstrual cycle. Am. J. Obstet. Gynecol. 54:861-866.
36. Lambden, P. R., J. E. Heckels, and P. J. Watt. 1982. Effect of anti-pilus antibodies on survival of gonococci within guinea pig subcutaneous chambers. Infect. Immun. 38:27-30.
37. Lee, B. C., and A. B. Schryvers. 1988. Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol. Microbiol. 2:827-829.
38. Lin, L., P. Ayala, J. Larson, M. Mulks, M. Fukuda, S. R. Carlsson, C. Enns, and M. So. 1997. The Neisseria type 2 IgA1 protease cleaves LAMP1 and promotes survival of bacteria within epithelial cells. Mol. Microbiol. 24: 1983-1094.
39. Lowe, T. L., and S. J. Krauss. 1976. Quantitation of Neisseria gonorrhoeae from women with gonorrhea. J. Infect. Dis. 133:621-626.
40. McBride, H. M., P. R. Lamden, J. E. Heckels, and P. J. Watt. 1981. The role of outer membrane proteins in the survival of Neisseria gonorrhoeae P9 within guinea-pig subcutanous chambers. J. Gen. Microbiol. 126:63-67.
41. McCormack, W. M., and G. H. Reynolds. 1982. Effect of menstrual cycle and method of contraception on recovery of N. gonorrhoeae. JAMA 247:1292-1294.
42. Mickelson, P. A., and P. F. Sparling. 1981. Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect. Immun. 33:555-564.
43. Mrkic, B., J. Pavlovic, T. Rulicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7427.
44. Nowicki, S., M. G. Martens, and B. J. Nowicki. 1995. Gonococcal infection in a nonhuman host is determined by human complement C1q. Infect. Immun. 63:4790-4794.
45. Polissi, A., A. Pontiggia, G. Feger, M. Altieri, H. Mottl, L. Ferrari, and D. Simon. 1998. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66:5620-5629.
46. Porat, N., M. A. Apicella, and M. S. Blake. 1995. Neisseria gonorrhoeae utilizes and enhances the biosynthesis of the asialoglycoprotein receptor expressed on the surface of the hepatic HepG2 cell line. Infect. Immun. 63:1498-1506.
47. Pottratz, S. T., T. Bellido, H. Mocharia, D. Crabb, and S. C. Manolagas. 1994. 17 β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93:944-950.
48. Salit, I. E. 1982. The differential susceptibility of gonococcal opacity variants to sex hormones. Can. J. Biochem. 60:301-306.
49. Scheuerpflug, I., R. Thomas, R. Ryll, J. Pandit, and T. F. Meyer. 1999. Roles of PilC and PilE proteins in pilus-mediated adherence of Neisseria gonorrhoeae and Neisseria meningitidis to human erythrocytes and endothelial and epithelial cells. Infect. Immun. 67:834-843.
50. Schneider, H., J. M. Griffiss, J. W. Boslego, P. J. Hitchcock, K. M. Zahos, and M. A. Apicella. 1991. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174:1601-1605.
51. Seifert, H. S., C. J. Wright, A. E. Jerse, M. S. Cohen, and J. G. Cannon. 1994. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Invest. 93:2744-2749.
52. Sherwood, J. K., L. Zeitlin, X. Chen, K. J. Whaley, R. A. Cone, and W. M. Saltzman. 1996. Residence half-life of IgG administered topically to the mouse vagina. Biol. Reprod. 54:264-269.
53. Snell, G. D. 1941. Reproduction, p. 55-88. In G. D. Snell (ed.), Biology of the laboratory mouse. Dover Publications, Inc., New York, N.Y.
54. Streeter, P. R., and L. B. Corbeil. 1981. Gonococcal infection in endotoxin-resistant and endotoxin-susceptible mice. Infect. Immun. 32:105-110.
55. Swanson, J., K. Robbins, O. Barrera, D. Corwin, J. Boslego, J. Ciak, M. Blake, and M. J. Koomey. 1987. Gonococcal pilin variants in experimental gonorrhea. J. Exp. Med. 165:1344-1357.
56. Swanson, J., O. Barrera, J. Sola, and J. Boslego. 1988. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J. Exp. Med. 168:2121-2129.
57. Taylor-Robinson, D., P. M. Furr, and C. M. Hetherington. 1990. Neisseria gonorrhoeae colonises the genital tract of oestradiol-treated germ-free female mice. Microb. Pathog. 9:369-374.
58. U.S. Department of Health and Human Services. 1991. Pelvic inflammatory disease. Research directions in the 1990s. Sex. Transm. Dis. 18:46-64.
59. Virji, M., K. Makepeace, D. J. P. Ferguson, and S. M. Watt. 1996. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol. Microbiol. 22:941-950.
60. Washington, E., and P. Katz. 1991. Cost of and payment source for pelvic inflammatory disease. JAMA 13:2565-2569.
61. Westrom, L., and D. Eschenbach. 1999. Pelvic inflammatory disease, p. 783-809. In K. K. Holmes, P. F. Sparling, P. A. Mardh, S. M. Lemon, W. E. Stamm, P. Piot, and J. N. Wasserheit (ed.), Sexually transmitted diseases. McGraw-Hill Companies, Inc., New York, N.Y.
62. Williams, J. M., G. C. Chen, L. Zhu, and R. F. Rest. 1998. Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via Opa proteins and require host pyruvate for growth. Mol. Microbiol. 27:171-186.